GRACE :: Head/Neck Cancer

HPV

Denise Brock

ASCO 2017 – Head and Neck Cancer – New Data from ASCO 2017 on Weekly Cisplatin Regimens

Share

Dr. Jared Weiss, University of North Carolina School of Medicine

Dr. Siddharth Sheth, University of North Carolina

Joshua Bauml, MD, University of Pennsylvania


Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and Siddharth Sheth, Hematology Oncology Fellow at the University of North Carolina, gathered post meeting to discuss new information from ASCO 2017 regarding head and neck cancers.   In this roundtable video, the doctors discuss New Data from ASCO 2017 on Weekly Cisplatin Regimens.


 

 

 


 Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

  

     

 

 

 

 

 

 


Denise Brock

ASCO 2017 – Head and Neck Cancer – HPV Vaccination, Possible Prevention of an Epidemic of Head and Neck Cancer

Share

Dr. Jared Weiss, University of North Carolina School of Medicine

Dr. Siddharth Sheth, University of North Carolina

Joshua Bauml, MD, University of Pennsylvania


Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and Siddharth Sheth, Hematology Oncology Fellow at the University of North Carolina, gathered post meeting to discuss new information from ASCO 2017 regarding head and neck cancers.   In this roundtable video, the doctors discuss HPV Vaccination, Possible Prevention of an Epidemic of Head and Neck Cancer.


 

 

 


 Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

  

     

 

 

 

 

 

 


Late Stage Oropharynx Cancer, Introduction and Management by Dr. Geoffrey Geiger

Share

Graphic of lymphatic areas in the neckDr. Geoffrey Geiger, University of Pennsylvania, provides an introduction to head and neck cancer and the human papilloma virus.

 

[]

Late Stage Oropharynx Cancer, Introduction and Management Audio Podcast

 

What you will hear in part 1

  • Oropharynx cancer basics
  • Risk factors; and 
  • The role of HPV

 

Glossary of terms you will hear in part 1

For other cancer-related definitions, visit the National Cancer Institute’s online glossary at cancer.gov/dictionary.

  • Chemotherapy – Treatment with drugs that kill cancer cells.
  • Carcinogen – Any substance that causes cancer.
  • Cisplatin – A drug used to treat malignant head and neck cancer. Cisplatin contains the metal platinum. It kills cancer cells by damaging their DNA and stopping them from dividing.
  • Definitive treatment – The treatment plan for a disease or disorder that has been chosen as the best one for a patient after all other choices have been considered.
  • Human Papilloma Virus/HPV – A type of virus that can cause abnormal tissue growth (for example, warts) and other changes to cells. Infection for a long time with certain types of HPV can cause cervical cancer. HPV may also play a role in some other types of cancer, such as anal, vaginal, vulvar, penile, oropharyngeal, and squamous cell skin cancers. Also called human papillomavirus.
  • Lymph node – A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph nodes filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Also called lymph gland.
  • Multi-disciplinary – In medicine, a term used to describe a treatment planning approach or team that includes a number of doctors and other health care professionals who are experts in different specialties (disciplines). In cancer treatment, the primary disciplines are medical oncology (treatment with drugs), surgical oncology (treatment with surgery), and radiation oncology (treatment with radiation).
  • Oropharynx/Oropharyngeal cancer – Cancer that forms in tissues of the oropharynx (the part of the throat at the back of the mouth, including the soft palate, the base of the tongue, and the tonsils). Most oropharyngeal cancers are squamous cell carcinomas (cancer that begins in flat cells lining the oropharynx).
  • Premalignant cancer – A term used to describe a condition that may (or is likely to) become cancer. Also called precancerous.
  • Prophylactic – In medicine, something that prevents or protects.
  • Radiation therapy/Radiotherapy – The use of high-energy radiation from x-rays, gamma rays, neutrons, protons, and other sources to kill cancer cells and shrink tumors. Radiation may come from a machine outside the body (external-beam radiation therapy), or it may come from radioactive material placed in the body near cancer cells (internal radiation therapy). Systemic radiation therapy uses a radioactive substance, such as a radiolabeled monoclonal antibody, that travels in the blood to tissues throughout the body. 
  • Squamous cell carcinoma – Cancer of the head and neck that begins in squamous cells (thin, flat cells that form the surface of the skin, eyes, various internal organs, and the lining of hollow organs and ducts of some glands). Squamous cell carcinoma of the head and neck includes cancers of the nasal cavity, sinuses, lips, mouth, salivary glands, throat, and larynx (voice box). Most head and neck cancers are squamous cell carcinomas.

 


Dr West

Dr. Weiss on Caveats and Emerging Concepts on HPV in Head/Neck Cancer

Share

The second of two parts of the webinar by Dr. Jared Weiss on HPV in head/neck cancer focuses on some caveats about the early conclusions we’ve reached about HPV, then follows with a discussion of several new research questions being addressed by emerging  clinical trials in this population.

Here are the video and audio versions of this podcast, along with the associated transcript and figures:

Weiss HPV Pt 2 SCCHN Caveats and New Concepts Audio Podcast

Weiss HPV Pt 2 SCCHN Caveats and New Concepts Transcript

Weiss HPV Pt 2 SCCHN Caveats and New Concepts Figures

Continue reading


Dr West

Dr. Weiss on the Importance of HPV in Head and Neck Cancer, Part 1

Share

What is HPVDr. Jared Weiss, specialist in head/neck and lung cancer at the University of North Carolina-Chapel Hill, contributed another excellent presentation recently on a topic in head and neck cancer that is dramatically changing the field as oncologists learn more about it. The human papilloma virus, or HPV, has long been known to be a critical factor in cervical cancer and some other cancer settings, but it has only been in recent years that we have begun to truly appreciate the magnitude of its impact in head and neck cancer and its potential relevance in practical management of head/neck cancer.  

Here is the first part of Dr. Weiss’s two-part program on HPV, focusing initially on defining HPV and its potential significance.

Weiss HPV Pt 1 Audio Podcast

Weiss HPV Pt 1 Transcript

Weiss HPV Pt 1 Figures

Continue reading


Ask Us, Q&A
Head/Neck Cancer Expert Content

Archives

Share

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243